Photo from David Steensma/X
Aug 25, 2023, 18:25
David Steensma: I’m excited to have started this new role as Chief Medical Officer of AjaxTherapeutics.
Quoting David Steensma, former Global Head of Hematology at Novartis Institutes for BioMedical Research (NIBR), on X/Twitter:
“I’m excited to have started this new role as Chief Medical Officer of Ajax Therapeutics, focused on developing new medicines for patients with myeloid neoplasms. It is a terrific team and brilliant group of founders led by Ross Levine.”
For details click here.
Source: David Steensma/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 09:22
Dec 21, 2024, 09:06
Dec 21, 2024, 09:00
Dec 21, 2024, 08:51
Dec 21, 2024, 08:48
Dec 21, 2024, 08:42
Dec 21, 2024, 08:37
Dec 21, 2024, 08:29
Dec 21, 2024, 08:12